Litcius/Paper detail

Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial

Filip K. Knop, George Kunos, Dror Dicker, Jean‐Sébastien Paquette, Louis J. Aronne, Ofir Frenkel, Thomas Holst‐Hansen, Karine Lalonde, Jisoo Lee, Glenn Crater

2025The Lancet Diabetes & Endocrinology10 citationsDOIOpen Access PDF

Topics & Concepts

MedicineObesityInternal medicineMEDLINEPhase (matter)Clinical trialDiabetes mellitusIntensive care medicinePediatricsWeight lossBody weightPhysical therapyEndocrinologyCannabis and Cannabinoid ResearchPharmacology and Obesity TreatmentForensic Toxicology and Drug Analysis